- Home
- AEMD vs CWD Comparison
AEMD vs CWD Comparison
Compare AEMD & CWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEMD
- CWD
- Stock Information
- Founded
- AEMD 1984
- CWD 2009
- Country
- AEMD United States
- CWD United States
- Employees
- AEMD N/A
- CWD N/A
- Industry
- AEMD Medical/Dental Instruments
- CWD Real Estate
- Sector
- AEMD Health Care
- CWD Finance
- Exchange
- AEMD Nasdaq
- CWD Nasdaq
- Market Cap
- AEMD 4.1M
- CWD 4.5M
- IPO Year
- AEMD N/A
- CWD 2023
- Fundamental
- Price
- AEMD $0.66
- CWD $2.10
- Analyst Decision
- AEMD Buy
- CWD
- Analyst Count
- AEMD 2
- CWD 0
- Target Price
- AEMD $28.75
- CWD N/A
- AVG Volume (30 Days)
- AEMD 8.5M
- CWD 9.6M
- Earning Date
- AEMD 08-13-2025
- CWD 08-13-2025
- Dividend Yield
- AEMD N/A
- CWD N/A
- EPS Growth
- AEMD N/A
- CWD N/A
- EPS
- AEMD N/A
- CWD N/A
- Revenue
- AEMD N/A
- CWD $32,323,000.00
- Revenue This Year
- AEMD N/A
- CWD N/A
- Revenue Next Year
- AEMD N/A
- CWD $56.47
- P/E Ratio
- AEMD N/A
- CWD N/A
- Revenue Growth
- AEMD N/A
- CWD N/A
- 52 Week Low
- AEMD $0.69
- CWD $1.63
- 52 Week High
- AEMD $8.44
- CWD $15.80
- Technical
- Relative Strength Index (RSI)
- AEMD 36.83
- CWD 45.49
- Support Level
- AEMD $0.69
- CWD $1.68
- Resistance Level
- AEMD $2.10
- CWD $4.31
- Average True Range (ATR)
- AEMD 0.30
- CWD 0.51
- MACD
- AEMD -0.10
- CWD 0.03
- Stochastic Oscillator
- AEMD 0.54
- CWD 15.61
About AEMD Aethlon Medical Inc.
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.
About CWD CaliberCos Inc.
CaliberCos Inc is an asset management firm whose primary goal is to enhance the wealth of investors seeking to make investments in middle-market assets. The company's funds include investment vehicles focused on real estate, private equity, and debt facilities. The company earns asset management fees calculated as a percentage of managed capital in funds and offerings. The company markets services through direct sales to private investors, wholesaling to investment advisers, direct sales to family offices and institutions and through in-house client services. The company operates into three reportable segments: Fund Management, Development, and Brokerage. The majority of revenue is derived from the fund management fees segment.